An assessment of the CHIP/medicaid quality measure for ADHD

Justin Blackburn, David J. Becker, Michael A. Morrisey, Meredith L. Kilgore, Bisakha Sen, Cathy Caldwell, Nir Menachemi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives: We analyzed a standard children's quality measure for attention-deficit/hyperactivity disorder (ADHD) using data from a single state to understand the characteristics of those meeting the measure, potential barriers to meeting the measure, and how meeting the measure affected outcomes. Study Design: Retrospective study using claims from Alabama's Children's Health Insurance Program from 1999 to 2012. Methods: We calculated the quality measure for ADHD care, as specified within CMS' Child Core Set and with an expanded denominator. We described the eligible population meeting the measure, assessed potential barriers, and measured the association with health expenditures using logit regressions and log-Poisson models. Results: Among those receiving ADHD medication, 11% of enrollees were eligible for annual measure calculation during our study period. Calculated as specified by CMS, 38% of enrollees met the measure. Using an expanded denominator of 7615 eligible medication episodes, 14% met all aspects of the measure. Primary reasons for failing to meet the measure were lacking medication coverage (64%) and lacking a follow-up visit within 30 days (62%). The rate of meeting the measure decreased with age and was lower for black enrollees. Health service utilization and costs were greater among children meeting the measure. Conclusions: Too few children are eligible for inclusion, and systematic differences exist among those who meet the measure. The measure may be sensitive to arbitrary criteria while missing potentially relevant clinical care. Refinements to the measure should be considered to improve generalizability to all children with ADHD and improve clinical relevance. States must consider additional analyses to direct quality improvement.

Original languageEnglish (US)
Pages (from-to)e1-e9
JournalAmerican Journal of Managed Care
Volume23
Issue number1
StatePublished - Jan 1 2017

Fingerprint

Medicaid
Attention Deficit Disorder with Hyperactivity
Health Expenditures
Quality Improvement
Health Care Costs
Health Services
Retrospective Studies
Outcome Assessment (Health Care)
Population

ASJC Scopus subject areas

  • Health Policy

Cite this

Blackburn, J., Becker, D. J., Morrisey, M. A., Kilgore, M. L., Sen, B., Caldwell, C., & Menachemi, N. (2017). An assessment of the CHIP/medicaid quality measure for ADHD. American Journal of Managed Care, 23(1), e1-e9.

An assessment of the CHIP/medicaid quality measure for ADHD. / Blackburn, Justin; Becker, David J.; Morrisey, Michael A.; Kilgore, Meredith L.; Sen, Bisakha; Caldwell, Cathy; Menachemi, Nir.

In: American Journal of Managed Care, Vol. 23, No. 1, 01.01.2017, p. e1-e9.

Research output: Contribution to journalArticle

Blackburn, J, Becker, DJ, Morrisey, MA, Kilgore, ML, Sen, B, Caldwell, C & Menachemi, N 2017, 'An assessment of the CHIP/medicaid quality measure for ADHD', American Journal of Managed Care, vol. 23, no. 1, pp. e1-e9.
Blackburn J, Becker DJ, Morrisey MA, Kilgore ML, Sen B, Caldwell C et al. An assessment of the CHIP/medicaid quality measure for ADHD. American Journal of Managed Care. 2017 Jan 1;23(1):e1-e9.
Blackburn, Justin ; Becker, David J. ; Morrisey, Michael A. ; Kilgore, Meredith L. ; Sen, Bisakha ; Caldwell, Cathy ; Menachemi, Nir. / An assessment of the CHIP/medicaid quality measure for ADHD. In: American Journal of Managed Care. 2017 ; Vol. 23, No. 1. pp. e1-e9.
@article{9622677ae2854a54b2a346251c524957,
title = "An assessment of the CHIP/medicaid quality measure for ADHD",
abstract = "Objectives: We analyzed a standard children's quality measure for attention-deficit/hyperactivity disorder (ADHD) using data from a single state to understand the characteristics of those meeting the measure, potential barriers to meeting the measure, and how meeting the measure affected outcomes. Study Design: Retrospective study using claims from Alabama's Children's Health Insurance Program from 1999 to 2012. Methods: We calculated the quality measure for ADHD care, as specified within CMS' Child Core Set and with an expanded denominator. We described the eligible population meeting the measure, assessed potential barriers, and measured the association with health expenditures using logit regressions and log-Poisson models. Results: Among those receiving ADHD medication, 11{\%} of enrollees were eligible for annual measure calculation during our study period. Calculated as specified by CMS, 38{\%} of enrollees met the measure. Using an expanded denominator of 7615 eligible medication episodes, 14{\%} met all aspects of the measure. Primary reasons for failing to meet the measure were lacking medication coverage (64{\%}) and lacking a follow-up visit within 30 days (62{\%}). The rate of meeting the measure decreased with age and was lower for black enrollees. Health service utilization and costs were greater among children meeting the measure. Conclusions: Too few children are eligible for inclusion, and systematic differences exist among those who meet the measure. The measure may be sensitive to arbitrary criteria while missing potentially relevant clinical care. Refinements to the measure should be considered to improve generalizability to all children with ADHD and improve clinical relevance. States must consider additional analyses to direct quality improvement.",
author = "Justin Blackburn and Becker, {David J.} and Morrisey, {Michael A.} and Kilgore, {Meredith L.} and Bisakha Sen and Cathy Caldwell and Nir Menachemi",
year = "2017",
month = "1",
day = "1",
language = "English (US)",
volume = "23",
pages = "e1--e9",
journal = "American Journal of Managed Care",
issn = "1088-0224",
publisher = "Ascend Media",
number = "1",

}

TY - JOUR

T1 - An assessment of the CHIP/medicaid quality measure for ADHD

AU - Blackburn, Justin

AU - Becker, David J.

AU - Morrisey, Michael A.

AU - Kilgore, Meredith L.

AU - Sen, Bisakha

AU - Caldwell, Cathy

AU - Menachemi, Nir

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objectives: We analyzed a standard children's quality measure for attention-deficit/hyperactivity disorder (ADHD) using data from a single state to understand the characteristics of those meeting the measure, potential barriers to meeting the measure, and how meeting the measure affected outcomes. Study Design: Retrospective study using claims from Alabama's Children's Health Insurance Program from 1999 to 2012. Methods: We calculated the quality measure for ADHD care, as specified within CMS' Child Core Set and with an expanded denominator. We described the eligible population meeting the measure, assessed potential barriers, and measured the association with health expenditures using logit regressions and log-Poisson models. Results: Among those receiving ADHD medication, 11% of enrollees were eligible for annual measure calculation during our study period. Calculated as specified by CMS, 38% of enrollees met the measure. Using an expanded denominator of 7615 eligible medication episodes, 14% met all aspects of the measure. Primary reasons for failing to meet the measure were lacking medication coverage (64%) and lacking a follow-up visit within 30 days (62%). The rate of meeting the measure decreased with age and was lower for black enrollees. Health service utilization and costs were greater among children meeting the measure. Conclusions: Too few children are eligible for inclusion, and systematic differences exist among those who meet the measure. The measure may be sensitive to arbitrary criteria while missing potentially relevant clinical care. Refinements to the measure should be considered to improve generalizability to all children with ADHD and improve clinical relevance. States must consider additional analyses to direct quality improvement.

AB - Objectives: We analyzed a standard children's quality measure for attention-deficit/hyperactivity disorder (ADHD) using data from a single state to understand the characteristics of those meeting the measure, potential barriers to meeting the measure, and how meeting the measure affected outcomes. Study Design: Retrospective study using claims from Alabama's Children's Health Insurance Program from 1999 to 2012. Methods: We calculated the quality measure for ADHD care, as specified within CMS' Child Core Set and with an expanded denominator. We described the eligible population meeting the measure, assessed potential barriers, and measured the association with health expenditures using logit regressions and log-Poisson models. Results: Among those receiving ADHD medication, 11% of enrollees were eligible for annual measure calculation during our study period. Calculated as specified by CMS, 38% of enrollees met the measure. Using an expanded denominator of 7615 eligible medication episodes, 14% met all aspects of the measure. Primary reasons for failing to meet the measure were lacking medication coverage (64%) and lacking a follow-up visit within 30 days (62%). The rate of meeting the measure decreased with age and was lower for black enrollees. Health service utilization and costs were greater among children meeting the measure. Conclusions: Too few children are eligible for inclusion, and systematic differences exist among those who meet the measure. The measure may be sensitive to arbitrary criteria while missing potentially relevant clinical care. Refinements to the measure should be considered to improve generalizability to all children with ADHD and improve clinical relevance. States must consider additional analyses to direct quality improvement.

UR - http://www.scopus.com/inward/record.url?scp=85011705782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011705782&partnerID=8YFLogxK

M3 - Article

C2 - 28141934

AN - SCOPUS:85011705782

VL - 23

SP - e1-e9

JO - American Journal of Managed Care

JF - American Journal of Managed Care

SN - 1088-0224

IS - 1

ER -